Alambic Investment Management, L.P. - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 72 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Alambic Investment Management, L.P. ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q3 2020$114,000
-50.9%
54,164
-11.7%
1.25%
+114.8%
Q2 2020$232,000
+98.3%
61,364
-0.6%
0.58%
+105.7%
Q1 2020$117,000
-52.6%
61,764
-47.8%
0.28%
+36.7%
Q4 2019$247,000
+135.2%
118,364
+170.2%
0.21%
+162.0%
Q3 2019$105,000
+59.1%
43,803
+106.9%
0.08%
+92.7%
Q2 2019$66,00021,1700.04%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q4 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 978,907$6,865,0003.28%
RA Capital Management 2,690,702$20,449,0002.02%
NEA Management Company, LLC 2,141,308$16,274,0001.04%
Broadfin Capital, LLC 1,656,705$10,911,0000.67%
Tredje AP-fonden 909,581$6,913,0000.44%
Granite Point Capital Management, L.P. 388,945$2,679,0000.40%
Ghost Tree Capital, LLC 72,726$553,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 181,818$1,382,0000.20%
Tower Research Capital LLC (TRC) 1,094$8,0000.00%
ACADIAN ASSET MANAGEMENT LLC 1,373$10,0000.00%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders